We are the Pannexin company
Developing life transforming therapies
based on blocking Pannexin 1 channels
Targeting chronic pain,
and other severe diseases
Our focus is to develop life- transforming therapies, based on blocking Pannexin1 channels.
We are the first in transforming this new pharmacological target into a new therapeutic approach for many severe diseases with high unmet medical need.
Discover our science
Panx1 is a new, exciting and validated pharmacological target with applications in many therapeutic areas and diseases like pain, cancer, autism, epilepsy, migraine, inflammation.See our science